acebutolol has been researched along with Necrotizing Enterocolitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, MT; Besner, GE; Conces, M; Duff, AF; Dumbauld, Z; Goodman, SD; Mihi, B; Narayanan, S; Purayil, N; Ragan, MV; Rajab, A; Sajankila, N; Volpe, SG; Wala, SJ; Wang, Y; Wickham, J | 1 |
| Griffin, MP; Hansen, JW | 1 |
1 trial(s) available for acebutolol and Necrotizing Enterocolitis
| Article | Year |
|---|---|
Can the elimination of lactose from formula improve feeding tolerance in premature infants?
Topics: Enterocolitis, Necrotizing; Female; Humans; Infant Food; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lactose; Lactose Intolerance; Male; Maltose; Milk, Human; Multivariate Analysis; Prospective Studies; Weight Gain | 1999 |
1 other study(ies) available for acebutolol and Necrotizing Enterocolitis
| Article | Year |
|---|---|
Superior performance of biofilm versus planktonic Limosilactobacillus reuteri in protection of the intestines and brain in a piglet model of necrotizing enterocolitis.
Topics: Animals; Biofilms; Brain; Enterocolitis, Necrotizing; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Intestines; Limosilactobacillus reuteri; Maltose; Probiotics; RNA, Ribosomal, 16S; Swine | 2023 |